These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8438431)

  • 1. Renal transplantation: nifedipine for the nonstarters? A prospective randomised study.
    Donnelly PK; Feehally J; Jurewicz A; Furness P; McCullough T; Harper SJ; Moorhouse J; Morgan J; Kehinde EO; Horsburgh T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):600-1. PubMed ID: 8438431
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.
    Morales JM; Andres A; Rodriguez Paternina E; Alcazar JM; Montoyo C; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):89-91. PubMed ID: 1347185
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 4. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
    Morales JM; Rodriguez-Paternina E; Araque A; Andres A; Hernandez E; Ruilope LM; Rodicio JL
    Transplant Proc; 1994 Oct; 26(5):2598-9. PubMed ID: 7940807
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
    Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
    Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
    Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
    Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 10. Initiation of ALG pretransplant reduces the incidence of delayed renal allograft function.
    Hong JH; Sumrani N; Cacciarelli TV; Distant D; Sommer BG
    Transplant Proc; 1993 Feb; 25(1 Pt 1):581-2. PubMed ID: 8438423
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.
    Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin A; Stenzel KH
    Transplant Proc; 1996 Jun; 28(3):1309-10. PubMed ID: 8658672
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
    Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J
    Transplant Proc; 1994 Oct; 26(5):2944-8. PubMed ID: 7940929
    [No Abstract]   [Full Text] [Related]  

  • 14. Is a late graft biopsy at 3 years after transplantation effective for improving the long-term outcome of renal allografts using cyclosporine?
    Morozumi K; Takeda A; Uchida K; Oda A; Oikawa T; Sugito K; Kodera K; Fujinami T; Tominaga Y; Yoshida A
    Transplant Proc; 1994 Apr; 26(2):945-8. PubMed ID: 8171713
    [No Abstract]   [Full Text] [Related]  

  • 15. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts.
    Morozumi K; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):537-9. PubMed ID: 8438404
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine lowers the incidence of delayed graft function in transplanted kidney patients treated with cyclosporine A.
    Carmellini M; Romagnoli J; Giulianotti PC; Pietrabissa A; Di Stefano R; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1994 Oct; 26(5):2626-9. PubMed ID: 7940818
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of nifedipine on renal allograft function and survival beyond one year.
    Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH
    Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.